The expected end of enhanced tax credits for ACA plans and “a market-wide morbidity shift” will add to insurers’ financial ...

Analysts have provided Elevance Health with 11 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $476.73, suggesting a potential 41.8% upside.

Analysts generally have a positive outlook for Elevance Health, with an ‘Outperform’ consensus rating and a decent potential ...

PHILADELPHIA, July 03, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the ...

Elevance Health (NYSE: ELV) will release second quarter 2025 financial results on July 17, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its ...

LOS ANGELES, July 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elevance Health, Inc. ("Elevance ...

Five cardiology and one radiology advocacy groups have called on Elevance Health to review its latest coverage guidelines for the treatment of varicose veins. The insurer’s guidelines, published ...

If you suffered losses exceeding $100,000 in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

LOS ANGELES, June 26, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Elevance Health, ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive ...

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ELEVANCE HEALTH, INC. (ELV), CLICK HERE BEFORE JULY 11, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

UnitedHealthcare, Indianapolis-based Elevance Health, CVS Health's Aetna, Cigna and more than 40 other insurers say they plan to reduce the scope of health care claims subject to prior authorization.